Diclofenac for the Prevention of Post-ERCP Pancreatitis in Higher Risk Patients

NCT00428025 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

23

Enrollment

OTHER

Sponsor class

Stopped slow recruitment

Conditions

Pancreatitis

Interventions

DRUG: diclofenac
DRUG: placebo

Sponsor

Queen's University